Apteki 36.6 Financial Statements (APTK)

Аптечная сеть 36,6smart-lab.ru   2021 2022 2023 2024 2025   LTM ?
Report date 08.08.2023 17.07.2023 02.05.2024 29.04.2025 29.04.2026   29.04.2026
Currency RUB RUB RUB RUB RUB   RUB
Financial report URL  
Annual report URL  
Presentation URL  
Number of stores, pcs. 2 554 2 753   2 753
New stores opened, pcs. 403 199  
Like for like sales, % ? 7.9%  
Online Sales, bln rub 30.0  
Revenue, bln rub ? 44.1 59.1 67.4 87.2 105.6   105.6
Operating Income, bln rub 4.27 6.77 9.96   9.96
EBITDA, bln rub ? 5.89 13.2 16.3   16.3
Net profit, bln rub ? -0.950 0.223 0.921 0.866 0.263   0.263
Net profit not adj., bln rub ? 0.120 0.267  
OCF, bln rub ? 3.23 6.60 7.05 6.49 5.07   5.07
CAPEX, bln rub ? 0.980 0.980 1.28 1.51 1.87   1.87
FCF, bln rub ? -1.71 1.64 1.93 0.450 -0.397   -0.397
Ordinary share dividend yield, % 0.0% 0.0% 0.0% 0.0% 0.0%   0.0%
Dividend payout ratio, % 0% 0% 0% 0% 0%   0
OPEX, bln rub 18.1 22.0 25.3   25.3
Cost of production, bln rub 29.0 38.9 45.1 58.7 70.7   70.7
Amortization, bln rub 5.8 5.8 6.0 6.6 6.4   6.4
Employment expenses, bln rub 6.78 7.92 8.91 11.6 14.1   14.1
Interest expenses, bln rub 4.92 4.27 2.44 3.95 4.97   4.97
Assets, bln rub 37.8 43.6 53.2 60.8 64.1   64.1
Net Assets, bln rub ? -6.65 -6.41 -6.83 -7.56 -7.30   -7.30
Debt, bln rub 21.6 18.9 20.7 23.1 23.2   23.2
Cash, bln rub 1.73 0.810 2.09 1.96 1.36   1.36
Net debt, bln rub 19.9 18.1 18.6 21.2 21.8   21.8
Ordinary share price, rub 14.0 11.6 14.2 11.5 8.49   4.61
Number of ordinary shares, mln 2 331 2 331 7 630 7 630 7 630   7 630
Free Float, % 6.00%   6.00%
Market cap, bln rub 32.5 27.0 108.5 87.7 64.8   35.2
EV, bln rub ? 52.4 45.1 127.1 108.9 86.6   57.0
Book value, bln rub -19.5 -19.9 -24.0 -27.2 -27.0   -27.0
EPS, rub ? -0.41 0.10 0.12 0.11 0.03   0.03
FCF/share, rub -0.73 0.70 0.25 0.06 -0.05   -0.05
BV/share, rub -8.37 -8.54 -3.15 -3.56 -3.54   -3.54
EBITDA margin, % ? 0.0% 0.0% 8.7% 15.1% 15.5%   15.5%
Net margin, % ? -2.2% 0.4% 1.4% 1.0% 0.2%   0.2%
FCF yield, % ? -5.3% 6.1% 1.8% 0.5% -0.6%   -1.1%
ROE, % ? 14.3% -3.5% -13.5% -11.5% -3.6%   -3.6%
ROA, % ? -2.5% 0.5% 1.7% 1.4% 0.4%   0.4%
P/E ? -34.2 120.9 117.8 101.3 246.3   133.9
P/FCF -19.0 16.4 56.2 195.0 -163.1   -88.7
P/S ? 0.74 0.46 1.61 1.01 0.61   0.33
P/BV ? -1.67 -1.35 -4.52 -3.23 -2.40   -1.30
EV/EBITDA ? 21.6 8.28 5.30   3.49
Debt/EBITDA 3.16 1.61 1.33   1.33
R&D/CAPEX, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
CAPEX/Revenue, % 2% 2% 2% 2% 2%   2%
Apteki 36.6 shareholders